Companies
SCIEX
the CESI 8000 Plus couples capillary electrophoresis directly to electrospray-ionization mass spectrometry, and the BioPhase 8800 system adds a native fluorescence detection module for higher-sensitivity biopharma characterization.
- Country
- United States
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| analytics-pat | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Capillary electrophoresis for biopharma | analytics-pat | Low | → |
| Mass spectrometers for biopharma characterization | analytics-pat | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.